Dr Greg Pearce
Adjunct Associate Professor, School of Science and Technology
Qualifications
BPharm, Dip Hosp Pharm, PhD
Contact
| Email: | gregoryapearce@gmail.com |
| Room: | McClymont Building (W34) |
| Mobile: | 0409 301 851 |
Dr Greg Pearce has practiced as a pharmacist in NSW tertiary referral hospitals, academia and, over the last 22 years, within the Australian pharmaceutical industry. During his employment within the pharmaceutical industry, he has held senior operational and management roles in regulatory affairs, medical information, pharmacovigilance and health economics.
He has strong professional and academic interests in the quality use of medicines, and the science underpinning the discovery, development and post marketing stewardship of medicines. He was an Industry member on the Pharmaceutical Health and Rational Use of Medicines (PHARM) advisory committee from 2001 to 2008. He has been a member of the Australian Regulatory and Clinical Scientists association (ARCS) since 1989.
Affiliations
Registered Pharmacist
Member of the Pharmaceutical Society of Australia
Areas of Teaching
- The role of the pharmacist within the Pharmaceutical Industry.
- The regulation of medicines.
- The role of the pharmaceutical industry in QUM.
Research interests
- Quality use of medicines.
- Discovery, development, regulation and post marketing surveillance of medicines.
- The application of evidence to pharmaceutical decision making.
Selected Publications
Pearce G., Rifampicin for MRSA, Australian Prescriber, 33: 145-146, 2010.
Day R.O., Lu C.Y., Pearce G. and Grainger D., Pharmaceutical Benefits Scheme: Rapid change and impetus towards achieving Quality Use of Medicines, Journal of Pharmacy Practice and Research, 37: 4-5, 2007.
Pearce G., Regulating medicines – where do generics fit?, The Australian Health Consumer, 3: 9-10, 2006.
Pearce G.A., McLachlan A.J. and Ramzan I., Bioequivalence: How, Why and What Does it Really Mean? Journal of Pharmacy Practice and Research, 34: 195-200, 2004.
Grobler M.P., Macarounis-Kirchmann K., Pearce G.A. and Stafford M., Industry comment on the 1995 revised Australian pharmacoeconomics guidelines, Pharmacoeconomics, 9: 353-356, 1996.
Carey D.L., Day R.O., Cairns D.R., Pearce G.A., Wodak A.D. and Lauchlan R.L., An Attempt to Influence Hypnotic and Sedative Drug Use, Medical Journal of Australia, 156: 389-396, 1992.
Kino R.J., Day R.O., Pearce G.A. and Fulde R.W.O., Aminophylline in the Emergency Department, Chest, 100: 1572-1577,1991.
Kino R.J., Day R.O., Pearce G.A. and Fulde R.W.O., Bedside Measurement of Plasma Theophylline Concentration within the Emergency Department. Australian Journal of Hospital Pharmacy, 21: 292-294, 1991.
Fletcher S.C., Tett S.E., Montgomery W.S. and Pearce G.A., Clinical Application of a Predictive Model for Plasma Carbamazepine Concentrations. Australian Journal of Hospital Pharmacy, 21: 10-15, 1991.
Pearce G.A. and Day R.O., Compliance with Criteria Necessary for Effective Drug Concentration Monitoring. Therapeutic Drug montoring, 23: 250-257, 1990.